Paper219669
Sendai virus.
Ishida N and 1 other. Adv Virus Res, 1978. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Sendai virus. Papers, record 219669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219669
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoproteins | Major topic |
| Parainfluenza Virus 1, Human | Major topic |
| Paramyxoviridae Infections | Major topic |
| Viral Proteins | Major topic |
| Animals | |
| Cell Fusion | |
| Chick Embryo | |
| Hemagglutinins, Viral | |
| Hemolysis | |
| Male | |
| Mice | |
| Models, Biological | |
| Neuraminidase | |
| Trypsin |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40431748 | Recombinant Sendai Virus Vectors as Novel Vaccine Candidates Against Animal Viruses. | Viruses | 2025 | https://conductscience.org/library/papers/40431748 | PubMed |
| 40333329 | Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40333329 | PubMed |
| 37847710 | A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production. | Am J Physiol Lung Cell Mol Physiol | 2023 | https://conductscience.org/library/papers/37847710 | PubMed |
| 34072332 | Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses. | Viruses | 2021 | https://conductscience.org/library/papers/34072332 | PubMed |
| 33441338 | Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria. | J Virol | 2021 | https://conductscience.org/library/papers/33441338 | PubMed |
| 30547053 | Quantification of Infectious Sendai Virus Using Plaque Assay. | Bio Protoc | 2018 | https://conductscience.org/library/papers/30547053 | PubMed |
| 30370318 | Sendai Virus Propagation Using Chicken Eggs. | Bio Protoc | 2018 | https://conductscience.org/library/papers/30370318 | PubMed |
| 30352599 | RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication. | Virol J | 2018 | https://conductscience.org/library/papers/30352599 | PubMed |
| 30209189 | Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants. | J Immunol | 2018 | https://conductscience.org/library/papers/30209189 | PubMed |
| 26648515 | Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26648515 | PubMed |
| 21750677 | Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21750677 | PubMed |
| 20682364 | Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. | Vaccine | 2010 | https://conductscience.org/library/papers/20682364 | PubMed |
| 19200447 | Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. | Vaccine | 2009 | https://conductscience.org/library/papers/19200447 | PubMed |
| 18844597 | Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. | Expert Rev Vaccines | 2008 | https://conductscience.org/library/papers/18844597 | PubMed |
| 16051860 | An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters. | J Virol | 2005 | https://conductscience.org/library/papers/16051860 | PubMed |
| 15834752 | Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin. | Med Microbiol Immunol | 2005 | https://conductscience.org/library/papers/15834752 | PubMed |
| 15141002 | Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. | J Virol | 2004 | https://conductscience.org/library/papers/15141002 | PubMed |
| 12829830 | Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner. | J Virol | 2003 | https://conductscience.org/library/papers/12829830 | PubMed |
| 10400752 | Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. | J Virol | 1999 | https://conductscience.org/library/papers/10400752 | PubMed |
| 10074164 | Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. | J Virol | 1999 | https://conductscience.org/library/papers/10074164 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/219669
GET https://conductscience.org/api/papers/v1/219669/cited_by?page=2